Acacia Research (ACTG) insider plans potential sale of 32,188 shares on Nasdaq
Rhea-AI Filing Summary
Acacia Research Corporation (ACTG) has a notice from an affiliate indicating an intention to sell up to 32,188 shares of common stock, with an aggregate market value of $150,199.00, on or after August 12, 2026 on the Nasdaq Global Select Market.
The filing also lists prior issuances of restricted stock by the issuer for services rendered, including 30,534 shares granted on May 26, 2023 and 32,172 shares granted on May 30, 2025.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 32,188 shares
Aggregate market value: $150,199.00
Restricted stock grant: 30,534 shares
+2 more
5 metrics
Planned shares to be sold
32,188 shares
Common stock planned for sale on or after August 12, 2026
Aggregate market value
$150,199.00
Aggregate market value of the 32,188 shares planned for sale
Restricted stock grant
30,534 shares
Issuer grant of restricted stock on May 26, 2023 for services rendered
Restricted stock grant
32,172 shares
Issuer grant of restricted stock on May 30, 2025 for services rendered
Planned sale date
08/12/2026
Earliest date for proposed sale of 32,188 common shares
Key Terms
Form 144, restricted stock, Nasdaq Global Select
3 terms
Form 144 regulatory
"Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
restricted stock financial
"Grant of restricted stock | Issuer | | | 30534 | 05/26/2023"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Nasdaq Global Select market
"08/12/2026 | Nasdaq Global Select 144: Securities To Be Sold"
A Nasdaq Global Select listing is the highest-quality tier on the Nasdaq stock exchange, awarded to companies that meet the strictest financial, reporting and governance standards. Think of it as a “premium shelf” in a store: it signals stronger oversight, transparency and liquidity compared with lower tiers, which helps investors judge company reliability, compare risk, and may attract more institutional buyers.
FAQ
What does the ACTG Form 144 filing disclose about planned stock sales?
The filing discloses an intention to sell up to 32,188 shares of Acacia Research common stock with an aggregate market value of $150,199.00, expected to be sold on or after August 12, 2026 on the Nasdaq Global Select Market.
What prior restricted stock grants are referenced for ACTG in this Form 144?
The filing references issuer grants of restricted stock for services rendered: 30,534 shares granted on May 26, 2023 and 32,172 shares granted on May 30, 2025, both in Acacia Research common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.